Q3695265 (Q3695265): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in en: Setting new description)
(‎Created claim: summary (P836): The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy., translated_summary)
Property / summary
 
The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English)
Property / summary: The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English) / rank
 
Normal rank
Property / summary: The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English) / qualifier
 
point in time: 18 November 2021
Timestamp+2021-11-18T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 19:04, 18 November 2021

Project Q3695265 in France
Language Label Description Also known as
English
No label defined
Project Q3695265 in France

    Statements

    0 references
    182,127.0 Euro
    0 references
    404,728.53 Euro
    0 references
    45.0 percent
    0 references
    18 March 2016
    0 references
    31 October 2018
    0 references
    Université de Bourgogne
    0 references
    Le développement de nouveaux médicaments est un processus de plus en plus coûteux et compliqué sur le plan réglementaire comme technique; l’imagerie médicale dans ce contexte représente un axe stratégique pour l’économie. (French)
    0 references
    The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English)
    18 November 2021
    0 references

    Identifiers

    BG0005829
    0 references